The shares of Elon Musk's newly founded company, Neuralink, established two years ago with the aim of expanding brain chip implants, have reached a valuation of $7 billion after a $5 billion increase in less than two weeks. Reuters reported, citing stock market sources, that the value of this newly established company rose after Elon Musk announced on May 25 that the U.S. regulatory agency had approved the clinical trial of Neuralink's brain chip. According to the news agency, Neuralink shares have recently been offered to stock market investors at $55 per share. Kip Ludwig, a former program director of neural engineering at the U.S. National Institutes of Health, stated that he 'optimistically' believes the commercialization of Neuralink's brain implant will take at least another ten years. Previously, Neuralink, the maker of the brain implant owned by Elon Musk, announced that it had received the green light from the U.S. Food and Drug Administration to conduct its first clinical trial. The chip is inserted into the brain via surgery with the help of a robot and can decode brain activity and connect it to a computer. According to Musk, this chip is capable of restoring lost brain functions in individuals.
Elon Musk's New Company Becomes More Valuable; Neuralink's Value Increases by Five Billion Dollars in Less Than Two Weeks
Neuralink, Elon Musk's brain chip company, has seen its valuation rise by $5 billion in under two weeks, reaching $7 billion after FDA approval for clinical trials. This development highlights the potential for advanced brain-computer interfaces, which could take a decade to commercialize.
👥 Key Players
📰 What Happened
Neuralink's valuation surged by $5 billion to $7 billion following FDA approval for clinical trials of its brain chip technology. This marks a significant milestone in the development of brain-computer interfaces.
- Neuralink's shares are priced at $55 per share after the valuation increase.
- The brain chip aims to restore lost brain functions through surgical implantation.
💡 Why It Matters
📚 Background
Neuralink is at the forefront of developing brain implants that could help treat neurological disorders and enhance cognitive abilities. The field of brain-computer interfaces is emerging as a significant area of research and investment.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%